RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
RAPID MICRO BIOSYSTEMS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.77+0.01 (+1.20%)
Close on Oct 19, 2026
- Market cap
- $37.40M
- P/E (TTM)
- –
- Dividend yield
- –
Rapid Micro Biosystems statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Laboratory Analytical Instruments companies for comparison
Valuation
| Measure | Rapid Micro Biosystems | Industry median |
|---|---|---|
| Market Cap | $38.80M | $229.23M |
| Enterprise Value | $38.18M | $194.73M |
| PS Ratio | 1.10 | 3.14 |
| PB Ratio | 2.19 | 3.19 |
| P/TBV Ratio | 2.19 | 4.69 |
Enterprise value
| Measure | Rapid Micro Biosystems | Industry median |
|---|---|---|
| EV / Sales | 1.09 | 2.93 |
Income (trailing twelve months)
| Measure | Rapid Micro Biosystems | Industry median |
|---|---|---|
| Revenue | $35.18M | $102.39M |
| Operating Income | -$49.76M | -$4.31M |
| Net Income | -$51.20M | -$6.57M |
| EBITDA | -$46.78M | -$1.98M |
| EPS (Diluted) | -$1.12 | -$0.07 |
Margins
| Measure | Rapid Micro Biosystems | Industry median |
|---|---|---|
| Operating Margin | -141.5% | -6.04% |
| Profit Margin | -145.6% | -10.5% |
| EBITDA Margin | -133.0% | -2.67% |
| FCF Margin | -114.8% | -0.30% |
Returns
| Measure | Rapid Micro Biosystems | Industry median |
|---|---|---|
| Return on Equity (ROE) | -141.6% | -19.2% |
| Return on Assets (ROA) | -76.4% | -13.3% |
| Return on Invested Capital (ROIC) | -195.9% | -4.11% |
| Return on Capital Employed (ROCE) | -123.5% | -9.07% |
Growth
| Measure | Rapid Micro Biosystems | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 16.1% | 8.85% |
| Revenue Growth (3Y CAGR) | 25.2% | 7.08% |
| Revenue Growth (5Y CAGR) | 15.9% | 11.8% |
Balance sheet
| Measure | Rapid Micro Biosystems | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $19.77M | $37.33M |
| Total Debt | $19.14M | $72.66M |
| Net Cash (Debt) | $627.00K | $3.92M |
| Net Cash Per Share | $0.01 | $0.28 |
| Equity (Book Value) | $17.75M | $57.36M |
| Book Value Per Share | $0.35 | $2.81 |
| Tangible Book Value | $17.75M | $10.71M |
| Working Capital | $28.11M | $54.64M |
Financial position
| Measure | Rapid Micro Biosystems | Industry median |
|---|---|---|
| Current Ratio | 2.55 | 2.50 |
| Quick Ratio | 1.39 | 1.54 |
| Debt / Equity | 1.08 | 0.38 |
| Interest Coverage | -21.16 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Rapid Micro Biosystems | Industry median |
|---|---|---|
| Operating Cash Flow | -$40.06M | -$653.46K |
| Capital Expenditures | -$336.00K | -$3.69M |
| Free Cash Flow | -$40.39M | -$835.02K |
| FCF Per Share | -$0.81 | -$0.02 |
Efficiency
| Measure | Rapid Micro Biosystems | Industry median |
|---|---|---|
| Asset Turnover | 0.52 | 0.59 |
| Revenue Per Employee | $205.71K | $322.75K |
| Profits Per Employee | -$299.42K | -$52.11K |
| Employee Count | 171 | 197 |
Dividends and yields
| Measure | Rapid Micro Biosystems | Industry median |
|---|---|---|
| Earnings Yield | -131.9% | -6.92% |
| FCF Yield | -104.1% | -0.62% |
Shares
| Measure | Rapid Micro Biosystems | Industry median |
|---|---|---|
| Shares Outstanding | 50,159,600 | 44,856,700 |
| Shares Change (YoY) | 4.41% | 3.35% |
| Float | 26,493,100 | 36,934,400 |
| Shares Held by Insiders | 47.2% | 10.6% |
| Shares Held by Institutions | 34.9% | 63.5% |
Taxes
| Measure | Rapid Micro Biosystems | Industry median |
|---|---|---|
| Income Tax | $75.00K | $1.52M |
Scores
| Measure | Rapid Micro Biosystems | Industry median |
|---|---|---|
| Altman Z-Score | -14.22 | 1.95 |
| Piotroski F-Score | 2 | 5 |
Calculated by StockData from Rapid Micro Biosystems's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.